Recent 8-K filings for ALMR
Highest-materiality recent filing
Alamar Biosciences closes IPO of 12.9M shares at $17.00, raising ~$219.9M
- Completed IPO of 12,937,500 shares of common stock at $17.00 per share, including full exercise of underwriters' option for 1,687,500 shares.
- Aggross gross proceeds of approximately $219.9 million before underwriting discounts and offering expenses.
-
Alamar Q2 revenue $29.4M (+82% YoY); guides FY26 to $116-120M
Q2 revenue $29.4M, up 82% from $16.2M YoY; consumables +147% to $15.5M, instruments +35% to $7.8M.
-
Alamar Biosciences announces death of board member Ian Ratcliffe; board size reduced to five
Independent director Ian Ratcliffe, who served since February 2024, passed away on July 5, 2026.
-
Alamar Q1 revenue doubled to $26.0M; net loss $21.3M on convertible note remeasurement
Total revenue $26.0M, +99% YoY; consumable revenue surged 178% to $14.0M.
-
Alamar Biosciences closes IPO of 12.9M shares at $17.00, raising ~$219.9M
Completed IPO of 12,937,500 shares of common stock at $17.00 per share, including full exercise of underwriters' option for 1,687,500 shares.
Earnings & guidance
Materiality & sentiment trend
Max materiality 0.85 · Median 0.79 · Most common event earnings